The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | De La Rosa Abel | Director | Grant(A) | 17K | — | $0 |
| Jun 16, 2026 | Thomas John C | Director | Grant(A) | 17K | — | $0 |
| Jun 16, 2026 | Whitley Richard James | Director | Grant(A) | 17K | — | $0 |
| Jun 16, 2026 | Keefer David R | Director | Grant(A) | 17K | — | $0 |
| Mar 5, 2026 | Walsh Angela | Chief Financial Officer | Grant(A) | 83K | — | $0 |
| Mar 5, 2026 | Grosswald Ralph | SVP OF OPERATIONS | Grant(A) | 83K | — | $0 |
| Mar 5, 2026 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | Grant(A) | 83K | — | $0 |
| Mar 5, 2026 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 330K | — | $0 |
| Dec 4, 2025 | Walsh Angela | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Dec 4, 2025 | Grosswald Ralph | SVP OF OPERATIONS | Grant(A) | 150K | — | $0 |
| Dec 4, 2025 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | Grant(A) | 150K | — | $0 |
| Dec 4, 2025 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 460K | — | $0 |
| Nov 21, 2025 | Conjoint Inc. | Director, 10% Owner | Conversion(C) | 2.8M | — | — |
| Nov 21, 2025 | Conjoint Inc. | Director, 10% Owner | Conversion(C) | 21.6M | — | — |
| Nov 21, 2025 | Conjoint Inc. | Director, 10% Owner | Conversion(C) | 284 | — | $0 |
| Nov 21, 2025 | Conjoint Inc. | Director, 10% Owner | Conversion(C) | 2K | — | $0 |
| Jun 27, 2025 | De La Rosa Abel | Director | Grant(A) | 2K | — | $0 |
| Jun 27, 2025 | Walsh Angela | Chief Financial Officer | Grant(A) | 12K | — | $0 |
| Jun 27, 2025 | Keefer David R | Director | Grant(A) | 2K | — | $0 |
| Jun 27, 2025 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 40K | — | $0 |
| Jun 27, 2025 | Thomas John C | Director | Grant(A) | 2K | — | $0 |
| Jun 27, 2025 | Grosswald Ralph | SVP OF OPERATIONS | Grant(A) | 12K | — | $0 |
| Jun 27, 2025 | Whitley Richard James | Director | Grant(A) | 2K | — | $0 |
| Jun 27, 2025 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | Grant(A) | 12K | — | $0 |
| Jun 18, 2025 | De La Rosa Abel | Director | Grant(A) | 210 | — | $0 |
| Jun 18, 2025 | De La Rosa Abel | Director | Grant(A) | 210 | — | $0 |
| Jun 18, 2025 | Thomas John C | Director | Grant(A) | 210 | — | $0 |
| Jun 18, 2025 | Thomas John C | Director | Grant(A) | 210 | — | $0 |
| Jun 18, 2025 | Keefer David R | Director | Grant(A) | 210 | — | $0 |
| Jun 18, 2025 | Keefer David R | Director | Grant(A) | 210 | — | $0 |
| Jun 18, 2025 | Whitley Richard James | Director | Grant(A) | 210 | — | $0 |
| Jun 18, 2025 | Whitley Richard James | Director | Grant(A) | 210 | — | $0 |
| Mar 12, 2025 | CK Life Sciences Intl (Holdings) Inc | Director, 10% Owner | Grant(A) | 284 | $7.01 | $2K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).